A new study found that a multifaceted infection prevention and control intervention could at least temporarily thwart outbreaks of infections from the Klebsiella pneumoniae bacterium, a leading cause ...

Azetukalner, a Kv7 potassium channel opener, reduced the frequency of focal onset seizures by a placebo-adjusted rate of 42.7 ...

A graduate of the University of Ibadan inspires many as she shares what she did in 300‑level that made her finish from the ...

New $40 million raise brings Series A total to $100M, enabling advancement of VIM0423, a first-in-class oral therapeutic, into Phase 2 trials for isolated dystonia and for Parkinson’s diseaseFirst ...

A University of Ibadan law graduate celebrated earning a first-class degree despite not initially being interested. She shared her passion for sports law.

The hydrogel resolved lameness in 72% of horses treatedHorses provide a strong translational model for human osteoarthritis Clinical investigation authorized by Belgian regulatory authorityAllegro’s ...

The CBSE Class 12 Economics exam is scheduled for March 18, 2026. Subject expert Rakesh Mishra advises students to prioritize ...

Independent Data Monitoring Committee Recommends Discontinuation of Phase III Trial Following Futility Analysis SYDNEY, AUSTRALIA, March 13, 2026 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: ...

Teenagers are more interested in studying a trade now than they were ten years ago, new research has revealed, with TAFE the ...

First-in-human study underway evaluating anti-CD36 monoclonal antibody designed to restore metabolic fitness in exhausted T cells, reduce immunosuppressive cells, and enhance antitumor immunity Pilatu ...

Pfizer ( PFE) said its Phase 2 study of tilrekimig (PF-07275315), a trispecific antibody for atopic dermatitis, showed positive results.

Retrospective study finds link between blockbuster drugs and longer survival ...